Fierce Biotech10d
Arbor sails into rocky gene editing waters with $74M for rare liver disease therapy
As other gene editing programs fold or get sold, Arbor Biotechnologies has secured $73.9 million to advance its lead ...
Yahoo Finance2d
FDA Accepts Sanofi's Filing for Multiple Sclerosis Drug Tolebrutinib (Revised)
indications after the regulatory agency identified cases of drug-induced liver injury in some study participants who were administered the drug. The MG studies on tolebrutinib were eventually ...
Medical Xpress29d
Four immunoassays for neurofilament light chain show consistent performance in amyotrophic lateral sclerosis
More information: Etienne Mondesert et al, Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral Sclerosis, Neurology (2025). DOI: 10.1212/WNL ...
Yahoo Finance3d
FDA Accepts Sanofi's Filing for Multiple Sclerosis Drug Tolebrutinib
indications after the regulatory agency identified cases of drug-induced liver injury in some study participants who were administered the drug. The MG studies on tolebrutinib were eventually ...